Privia Health Reports First Quarter 2024 Financial Results

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)

Insights

In examining the Q1 report from Privia Health, notable elements include a 7.4% increase in Practice Collections and a 17.3% increase in Implemented Providers. This growth suggests effective scale-up in operations. The reported 18.1% rise in Adjusted EBITDA is a strong indicator of operational efficiency, which investors should appreciate as it provides insights on the company's profitability. However, the 87.7% decrease in Operating Income and a 59.3% decrease in Net Income year-over-year raise caution. Such variances could be due to one-time expenses or investments, like the non-cash stock compensation which increased significantly. The company's reiteration of full-year guidance implies management's confidence in their business model, which is reassuring for investment considerations. Capital expenditures remaining under $1 million suggests a lean approach to asset investment, which could bolster free cash flow – anticipated to be 80% of Adjusted EBITDA. The projected effective tax rate of 27-28% aligns with corporate norms.

From a healthcare industry perspective, the 10.2% increase in Value-Based Care Attributed Lives is a positive sign of Privia Health's positioning within the market. Value-Based Care is increasingly becoming the preferred model, as it aligns patient outcomes with cost efficiency. Privia's ability to grow in this domain shows their adaptability to industry trends. Furthermore, the significant addition to their Implemented Providers base can be seen as a strategic move to expand their network, which is critical in the fragmented healthcare market. The forward guidance on Practice Collections, despite anticipating a reduction due to changed Medicare Advantage capitation agreements, implies a clear strategy to optimize for economic terms over volume. When evaluating healthcare stocks, these indicators are vital for understanding a company's growth trajectory and operational focus.

05/09/2024 - 06:00 AM

Practice Collections +7.4% compared to 1Q’23
Implemented Providers +17.3% compared to 1Q’23
Company Reiterated Full Year 2024 Guidance

ARLINGTON, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2024.

	For the Three Months Ended March 31,
($ in millions, except per share amounts)		2024		2023	Change (%)

Total revenue	$	415.2	$	386.3	7.5		%
Gross profit	$	93.4	$	83.0	12.5		%
Operating income	$	0.8	$	6.7	(87.7	)	%
Net income ^a	$	3.0	$	7.3	(59.3	)	%
Non-GAAP adjusted net income ^b	$	22.5	$	19.3	16.6		%
Net income per share	$	0.03	$	0.06	(50.0	)	%
Non-GAAP adjusted net income per share	$	0.18	$	0.16	12.5		%

	a.	Net income for the three months ended March 31, 2024, included $11.9 million in non-cash stock compensation expense. Net income for the three months ended March 31, 2023 included $5.4 million in non-cash stock compensation expense.
	b.	Reconciliations of non-GAAP adjusted net income and other non-GAAP financial measures are presented in tables near the end of this press release.

First Quarter 2024 highlights include:

Practice Collections of $707.7M, +7.4% versus 1Q’23, which includes a year-over-year reduction due to a shift of capitation risk exposure for improved economic terms;
Adjusted EBITDA of $19.9M, +18.1% versus 1Q’23;
Continued strength in same-store growth and new provider additions, +17.3% versus 1Q’23; and
Strong sales and business development pipeline.

Key Operating and Non-GAAP Financial Metrics

	For the Three Months Ended March 31,
($ in millions)		2024		2023	Change (%)

Implemented Providers		4,359		3,716	17.3	%
Value-Based Care Attributed Lives		1,143,000		1,037,000	10.2	%
Practice Collections	$	707.7	$	658.9	7.4	%
Care Margin	$	94.9	$	84.0	13.0	%
Platform Contribution	$	44.7	$	41.4	8.1	%
Adjusted EBITDA	$	19.9	$	16.9	18.1	%

Financial and Business Outlook ^{c d e f}

Privia Health reiterated its full-year 2024 guidance, as follows:

	FY 2023		FY 2024 Guidance^c				Y-Y% Change from FY 2023
($ in millions)	Actual		Low		High		Low	High
Implemented Providers		4,305		4,650		4,750	8.0%	10.3%
Attributed Lives		1,120,000		1,150,000		1,200,000	2.7%	7.1%
Practice Collections	$	2,839.0	$	2,775	$	2,875	(2.3)%	1.3%
GAAP Revenue	$	1,657.7	$	1,600	$	1,675	(3.5)%	1.0%
Care Margin	$	359.2	$	388	$	400	8.0%	11.4%
Platform Contribution	$	173.5	$	180	$	188	3.7%	8.4%
Adjusted EBITDA^e	$	72.2	$	85	$	90	17.7%	24.7%

Practice Collections guidance includes reduction of approximately $198 million from renegotiated Medicare Advantage capitation agreements, and assumes minimal year-over-year increase in Shared Savings accruals
Adjusted EBITDA guidance includes approximately $10-12 million in start-up costs for new geographies announced in last 18 months
Capital expenditures are expected to be less than $1 million in full-year 2024
Approximately 80% of Adjusted EBITDA expected to convert to free cash flow in FY 2024
Effective tax rate expected to be approximately 27-28%

c.	Management has not reconciled forward-looking non-GAAP measures to their most directly comparable GAAP measures of gross margin, operating income and net income. This is because the Company cannot predict with reasonable certainty and without unreasonable efforts the ultimate outcome of certain GAAP components of such reconciliations due to market-related assumptions that are not within our control as well as certain legal or advisory costs, tax costs or other costs that may arise. For these reasons, management is unable to assess the probable significance of the unavailable information, which could materially impact the amount of the future directly comparable GAAP measures.
d.	See “Key Metrics and Non-GAAP Financial Measures” for more information as to how the Company defines and calculates Implemented Providers, Attributed Lives, Practice Collections, Care Margin, Platform Contribution, and Adjusted EBITDA, and for a reconciliation of the most comparable GAAP measures to Care Margin, Platform Contribution, Adjusted EBITDA, Adjusted Net Income and Adjusted Net Income Per Share.
e.	Certain non-recurring or non-cash and other expenses will be treated as an add back in the reconciliation of Net Income to Adjusted EBITDA, and the reconciliation of Net Income to Adjusted Net Income and Adjusted Net Income Per Share, the details of which can be found in the Reconciliation schedules near the end of this and in future quarterly financial press releases.
f.	Any slight variations in totals due to rounding.

Webcast and Conference Call Information

The Company will host a conference call on May 9, 2024, at 8:00 am ET to discuss these results and management’s outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/events-and-presentations to listen to the call via live webcast. The webcast will be archived and available for replay for on-demand listening shortly after the completion of the call under the same link. If you wish to participate in the live conference call, then please go to https://register.vevent.com/register/BIa226cff209a046a0ae8a7711f796fc02 to pre-register and obtain your dial-in number and passcode.

This news release and the financial statements contained herein, and the slide presentation for the webcast, are also available on the Privia Health Investor Relations website at ir.priviahealth.com.

About Privia Health

Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual settings. Our platform is led by top industry talent and exceptional physician leadership, and consists of scalable operations and end-to-end, cloud-based technology that reduces unnecessary healthcare costs, achieves better outcomes, and improves the health of patients and the well-being of providers. For more information, visit priviahealth.com.

Non-GAAP Financial Measures

The Company reports and discusses its operating results using financial measures consistent with accounting principles generally accepted in the United States ("GAAP"). From time to time, in press releases, financial presentations, earnings conference calls or otherwise, the Company may disclose certain non-GAAP financial measures. The non-GAAP financial measures presented in this press release should not be viewed as alternatives or substitutes for the Company's reported GAAP results. A reconciliation to the most directly comparable GAAP financial measure is set forth in the tables that accompany this release.

The Company believes that the non-GAAP financial measures presented in this press release are relevant and provide useful information to the Company's management, investors, and other interested parties about the Company's operating performance because the measures allow them to understand and compare the Company's actual and expected operating results during the prior, current and future periods in a more consistent manner. The non-GAAP measures presented in this press release may not be comparable to similarly titled measures used by other companies. These non-GAAP financial measures are used in addition to and in conjunction with results presented in accordance with GAAP and reflect an additional way of viewing aspects of the Company's operations that, when viewed with GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provides a more complete understanding of the results of operations and trends affecting the Company's business. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to financial measures calculated in accordance with GAAP.

Safe Harbor Statement

The financial results in this press release reflect preliminary, unaudited results, which are not final until the Company’s Form 10-Q is filed with the Securities and Exchange Commission (“SEC”). This press release contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such statements relate to our current expectations, projections and assumptions about our business, the economy and future events or conditions. They do not relate strictly to historical or current facts. Forward-looking statements can be identified by words such as “aims,” “anticipates,” "assumes," “believes,” “estimates,” “expects,” “forecasts,” “future,” “intends,” “likely,” “may,” “outlook,” “plans,” “potential,” “projects,” “seeks,” “strategy,” “targets,” “trends,” “will,” “would,” “could,” “should,” and variations of such terms and similar expressions and references to guidance, although some forward-looking statements may be expressed differently. In particular, these include statements relating to, among other things: our future actions, business plans, objectives and prospects; and our future operating or financial performance and projections, including our full-year guidance for 2024. Factors or events that could cause actual results to differ may emerge from time to time and are difficult to predict. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results may differ materially from past results and those anticipated, estimated or projected. We caution you not to place undue reliance upon any of these forward-looking statements.

Factors related to these risks and uncertainties include, but are not limited to: compliance with applicable healthcare laws and government regulations in the heavily regulated industry in which the Company operates; the Company’s dependence on relationships with its medical groups, some of which the Company does not own; the Company’s growth strategy, which may not prove viable and the Company may not realize expected results; the Company’s inability to successfully enter new markets; difficulties implementing the Company’s proprietary end-to-end, cloud-based technology solution for Privia physicians and new medical groups; the high level of competition in the Company’s industry and the Company’s failure to compete and innovate; challenges in successfully establishing a presence in new geographic markets; the Company’s reliance on its electronic medical record vendor, which the Privia Technology Solution is integrated and built upon; changes in the payer mix of patients and potential decreases in the Company’s reimbursement rates as a result of consolidation among commercial payers; the Company’s use, disclosure, and other processing of personally identifiable information, including health information, is subject to the Health Insurance Portability and Accountability Act of 1996 and other federal and state privacy and security regulations; and those factors discussed under the caption “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and the Company’s subsequent Quarterly Reports on Form 10-Q. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information unless required by law.

Contact:
Robert Borchert
SVP, Investor & Corporate Communications
IR@priviahealth.com
817.783.4841


Privia Health Group, Inc.
Condensed Consolidated Statements of Operations^(g)
(unaudited)
(in thousands, except share and per share data)

	For the Three Months Ended March 31,
		2024			2023

Revenue	$	415,243		$	386,276

Operating expenses:
Provider expense		320,336			302,255
Cost of platform		54,057			44,730
Sales and marketing		6,085			5,286
General and administrative		32,121			25,951
Depreciation and amortization		1,821			1,340
Total operating expenses		414,420			379,562
Operating income		823			6,714
Interest income, net		(2,984	)		(1,813	)
Income before provision for income taxes		3,807			8,527
Provision for income taxes		751			2,125
Net income		3,056			6,402
Less: Net income (loss) attributable to non-controlling interests		72			(922	)
Net income attributable to Privia Health Group, Inc.	$	2,984		$	7,324
Net income per share attributable to Privia Health Group, Inc. stockholders – basic	$	0.03		$	0.06
Net income per share attributable to Privia Health Group, Inc. stockholders – diluted	$	0.02		$	0.06
Weighted average common shares outstanding – basic		118,505,320			115,009,010
Weighted average common shares outstanding – diluted		125,053,404			124,328,964

^(g) Any slight variations in totals due to rounding.


Privia Health Group, Inc.
Condensed Consolidated Balance Sheets^(h)
(in thousands)

	March 31, 2024			December 31, 2023
Assets	(unaudited)
Current assets:
Cash and cash equivalents	$	351,136		$	389,511
Accounts receivable		346,088			290,768
Prepaid expenses and other current assets		30,916			20,525
Total current assets		728,140			700,804
Non-current assets:
Property and equipment, net		2,038			2,325
Operating right-of-use asset		6,159			6,612
Intangible assets, net		106,103			107,630
Goodwill		139,457			138,749
Deferred tax asset		34,337			35,200
Other non-current assets		15,352			8,580
Total non-current assets		303,446			299,096
Total assets	$	1,031,586		$	999,900

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued expenses	$	50,651		$	57,831
Provider liability		350,286			326,078
Operating lease liabilities, current		2,861			3,043
Total current liabilities		403,798			386,952
Non-current liabilities:
Operating lease liabilities, non-current		4,651			5,246
Other non-current liabilities		313			313
Total non-current liabilities		4,964			5,559
Total liabilities		408,762			392,511
Commitments and contingencies
Stockholders’ equity:
Common stock		1,187			1,182
Additional paid-in capital		766,243			753,869
Accumulated deficit		(190,630	)		(193,614	)
Total Privia Health Group, Inc. stockholders’ equity		576,800			561,437
Non-controlling interest		46,024			45,952
Total stockholders’ equity		622,824			607,389
Total liabilities and stockholders’ equity	$	1,031,586		$	999,900

^(h) Any slight variations in totals are due to rounding.


Privia Health Group, Inc.
Condensed Consolidated Statements of Cash Flows⁽ⁱ⁾
(unaudited)
(in thousands)

	For the Three Months Ended March 31,
		2024			2023
Cash flows from operating activities
Net income	$	3,056		$	6,402
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation		294			291
Amortization of intangibles		1,527			1,049
Stock-based compensation		11,904			5,381
Deferred tax expense		863			1,865
Changes in asset and liabilities:
Accounts receivable		(55,320	)		(71,277	)
Prepaid expenses and other current assets		(10,391	)		(2,301	)
Other non-current assets and right-of-use asset		(1,321	)		493
Accounts payable and accrued expenses		(7,180	)		(6,537	)
Provider liability		24,208			51,944
Operating lease liabilities		(777	)		(694	)
Net cash used in operating activities		(33,137	)		(13,384	)
Cash from investing activities
Business acquisitions, net of cash acquired		(707	)		(24,856	)
Other		(5,006	)		—
Net cash used in investing activities		(5,713	)		(24,856	)
Cash flows from financing activities
Proceeds from exercised stock options		475			1,477
Net cash provided by financing activities		475			1,477
Net decrease in cash and cash equivalents		(38,375	)		(36,763	)
Cash and cash equivalents at beginning of period		389,511			347,992
Cash and cash equivalents at end of period	$	351,136		$	311,229

Supplemental disclosure of cash flow information:
Interest paid	$	93		$	22
Income tax refunds received	$	(230	)	$	(5	)

⁽ⁱ⁾ Any slight variations in totals are due to rounding.

Additional Financial Information

Revenues disaggregated by source:

	For the Three Months Ended March 31,
(Dollars in Thousands)		2024		2023
FFS-patient care	$	274,823	$	227,789
FFS-administrative services		29,076		26,396
Capitated revenue		51,304		78,260
Shared savings		47,464		43,928
Care management fees (PMPM)		10,603		8,558
Other revenue		1,973		1,345
Total Revenue	$	415,243	$	386,276

The Company’s liabilities for unpaid medical claims under at-risk capitation arrangements:

	March 31,
(Dollars in Thousands)		2024			2023
Balance, beginning of period	$	67,138		$	28,617
Incurred health care costs:
Current year		51,040			75,632
Prior years		600			3,268
Total claims incurred	$	51,640		$	78,900
Claims paid:
Current year		(2,072	)		(29,716	)
Prior year		(42,185	)		(28,079	)
Total claims paid	$	(44,257	)	$	(57,795	)
Balance, end of period	$	74,521		$	49,722

Key Metrics and Non-GAAP Financial Measures

Privia Health reviews a number of operating and financial metrics, including the following key metrics and non-GAAP financial measures, to evaluate the Company’s business, measure performance, identify trends affecting the Company’s business, formulate business plans, and make strategic decisions.

Key Metrics^(j)

	For the Three Months Ended March 31,
(unaudited; $ in millions)		2024		2023

Implemented Providers (as of end of period) ⁽¹⁾		4,359		3,716
Attributed Lives (as of end of period) ⁽²⁾		1,143,000		1,037,000
Practice Collections ⁽³⁾	$	707.7	$	658.9

⁽¹⁾Implemented Providers is defined as the total of all service professionals on Privia Health’s platform at the end of a given period who are credentialed by Privia Health and billed for medical services, in both Owned and Non-Owned Medical Groups during that period.
⁽²⁾Attributed Lives are defined as any patient that a payer deems attributed to Privia to deliver care as part of a value-based care arrangement through a provider of primary care services as of the end of a particular period.
⁽³⁾ Practice Collections are defined as the total collections from all practices in all markets and all sources of reimbursement that the Company receives for delivering care and providing Privia Health’s platform and associated services. Practice Collections differ from revenue by including collections from Non-Owned Medical Groups.
^(j)Any slight variations in totals are due to rounding.

Non-GAAP Financial Measures^(4)(k)

	For the Three Months Ended March 31,
(unaudited; $ in thousands)	2024			2023

Care Margin	$	94,907		$	84,021
Platform Contribution	$	44,737		$	41,398
Platform Contribution Margin		47.1	%		49.3	%
Adjusted EBITDA	$	19,922		$	16,864
Adjusted EBITDA Margin		21.0	%		20.1	%

⁽⁴⁾In addition to results reported in accordance with GAAP, Privia Health discloses Care Margin, Platform Contribution, Platform Contribution margin, Adjusted EBITDA and Adjusted EBITDA Margin, which are non-GAAP financial measures. Each are defined as follows:
	•	Care Margin is Gross Profit excluding amortization of intangible assets.
	•	Platform Contribution is Gross Profit, excluding amortization of intangible assets, less Cost of platform and excluding stock-based compensation expense included in Cost of platform.
	•	Platform Contribution margin is Platform Contribution divided by Care Margin.
	•	Adjusted EBITDA is net income attributable to Privia Health Group, Inc. shareholders and subsidiaries excluding non-controlling interests, provision for income taxes, interest income, interest expense, depreciation and amortization, stock-based compensation, employer taxes on equity vesting/exercises, severance charges and other non-recurring expenses.
	•	Adjusted EBITDA Margin is Adjusted EBITDA divided by Care Margin.
^(k) Any slight variations in totals are due to rounding.

Reconciliation of Gross Profit to Care Margin^(l)

	For the Three Months Ended March 31,
(unaudited; $ in thousands)		2024			2023
Revenue	$	415,243		$	386,276
Provider expense		(320,336	)		(302,255	)
Amortization of intangible assets		(1,527	)		(1,049	)
Gross Profit	$	93,380		$	82,972
Amortization of intangibles assets		1,527			1,049
Care margin	$	94,907		$	84,021
^(l) Any slight variations in totals are due to rounding.

Reconciliation of Gross Profit to Platform Contribution^(m)

	For the Three Months Ended March 31,
(unaudited; $ in thousands)		2024			2023
Revenue	$	415,243		$	386,276
Provider expense		(320,336	)		(302,255	)
Amortization of intangibles assets		(1,527	)		(1,049	)
Gross Profit	$	93,380		$	82,972
Amortization of intangibles assets		1,527			1,049
Cost of platform		(54,057	)		(44,730	)
Stock-based compensation⁽⁵⁾		3,887			2,107
Platform Contribution	$	44,737		$	41,398
^(m) Any slight variations in totals are due to rounding.
⁽⁵⁾ Amount represents stock-based compensation expense included in Cost of Platform.

Reconciliation of Net Income to Adjusted EBITDA⁽ⁿ⁾

	For the Three Months Ended March 31,
(unaudited; $ in thousands)		2024			2023
Net income	$	2,984		$	7,324
Net income (loss) attributable to non-controlling interests		72			(922	)
Provision for income taxes		751			2,125
Interest income, net		(2,984	)		(1,813	)
Depreciation and amortization		1,821			1,340
Stock-based compensation		11,904			5,381
Other expenses⁽⁶⁾		5,374			3,429
Adjusted EBITDA	$	19,922		$	16,864

⁽ⁿ⁾ Any slight variations in totals are due to rounding.
⁽⁶⁾Other expenses include employer taxes on equity vesting/exercises, severance and certain non-recurring costs.

Reconciliation of Net Income to Adjusted Net Income and Adjusted Net Income Per Share^(o)

	For the Three Months Ended March 31,
(unaudited; $ in thousands)		2024		2023
Net income	$	2,984	$	7,324
Stock-based compensation		11,904		5,381
Intangible amortization expense		1,527		1,049
Provision for income tax		751		2,125
Other expenses⁽⁷⁾		5,374		3,429
Adjusted net income	$	22,540	$	19,308
Adjusted net income per share attributable to Privia Health Group, Inc. stockholders – basic	$	0.19	$	0.17
Adjusted net income per share attributable to Privia Health Group, Inc. stockholders – diluted	$	0.18	$	0.16
Weighted average common shares outstanding – basic		118,505,320		115,009,010
Weighted average common shares outstanding – diluted		125,053,404		124,328,964
^(o) Any slight variations in totals due to rounding.
⁽⁷⁾Other expenses include employer taxes on equity vesting/exercises, severance and certain non-recurring costs.

FAQ

What was Privia Health Group's total revenue increase in the first quarter of 2024?

Privia Health Group reported a 7.5% increase in total revenue in the first quarter of 2024.

How much did the gross profit rise by in the first quarter of 2024?

The gross profit rose by 12.5% in the first quarter of 2024 compared to the previous year.

What was the percentage increase in non-GAAP adjusted net income in the first quarter of 2024?

The non-GAAP adjusted net income increased by 16.6% in the first quarter of 2024.

How much did the implemented providers increase by in the first quarter of 2024?

There was an increase of 17.3% in implemented providers in the first quarter of 2024.

Did Privia Health Group provide any guidance for the full year 2024?

Yes, the company reiterated its full-year 2024 guidance.

Privia Health Reports First Quarter 2024 Financial Results

Insights

FAQ

What was Privia Health Group's total revenue increase in the first quarter of 2024?

How much did the gross profit rise by in the first quarter of 2024?

What was the percentage increase in non-GAAP adjusted net income in the first quarter of 2024?

How much did the implemented providers increase by in the first quarter of 2024?

Did Privia Health Group provide any guidance for the full year 2024?

NASDAQ:PRVA

PRVA Rankings

PRVA Latest News

PRVA Stock Data

Trending News

Privia Health Reports First Quarter 2024 Financial Results

Insights

Financial Analyst neutral

Healthcare Industry Analyst positive

FAQ

What was Privia Health Group's total revenue increase in the first quarter of 2024?

How much did the gross profit rise by in the first quarter of 2024?

What was the percentage increase in non-GAAP adjusted net income in the first quarter of 2024?

How much did the implemented providers increase by in the first quarter of 2024?

Did Privia Health Group provide any guidance for the full year 2024?

NASDAQ:PRVA

PRVA Rankings

PRVA Latest News

PRVA Stock Data